Cite
HARVARD Citation
Lam, J. et al. (2019). A cost-effectiveness analysis of reslizumab in the treatment of poorly controlled eosinophilic asthma. Journal of asthma. pp. 872-881. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lam, J. et al. (2019). A cost-effectiveness analysis of reslizumab in the treatment of poorly controlled eosinophilic asthma. Journal of asthma. pp. 872-881. [Online].